The Problem with Amphotericin
Patient harm from inadvertent administration of amphotericin B (Fungizone™) instead of liposomal amphotericin (AmBisome ® ) has been described in the literature and has been the subject of patient safety alerts in the UK. Safe use of intravenous amphotericin depends on the knowledge and awareness of...
Saved in:
Published in | Clinical drug investigation Vol. 40; no. 8; pp. 687 - 693 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.08.2020
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!